Evidence map›Paper›PMID 22155078›Full record

ArticleJournal of molecular biology2012

Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily.

Stefan Gajewski, Evan Q Comeaux, Nauzanene Jafari, Nagakumar Bharatham, Donald Bashford, Stephen W White, Robert C A M van Waardenburg

Erratum issuedAbstract read
In one paragraph

Article in Journal of molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Zymolyase Treatment ofDNA and cell biology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Gene flow and biological conflict systems in the origin and evolution of eukaryotes.Frontiers in cellular and infection microbiology · 2012
    Article
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Stefan GajewskiDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Evan Q Comeaux
Nauzanene Jafari
Nagakumar Bharatham
Donald Bashford
Stephen W White
Robert C A M van Waardenburg
St. Jude Children's Research Hospital · USUniversity of Alabama at Birmingham · USUniversity of Tennessee Health Science Center · US

Funding

INTERACTIONS IN NONNATIVE STATES OF PROTEINSR01GM057513 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI CASE, DAVID A · 1998 to 2012
$3.3M
Development and Maintenance of the MEAD Software SuiteR01GM086243 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BASHFORD, DONALD E. · 2009 to 2012
$1.2M
NIGMS NIH HHS GM057513NIGMS NIH HHS GM0886243NIGMS NIH HHS R01 GM057513NIGMS NIH HHS R01 GM086243
6 · The paper itself

Abstract

Tyrosyl-DNA phosphodiesterase I (Tdp1) is a member of the phospholipase D superfamily that hydrolyzes 3'-phospho-DNA adducts via two conserved catalytic histidines-one acting as the lead nucleophile and the second acting as a general acid/base. Substitution of the second histidine specifically to arginine contributes to the neurodegenerative disease spinocerebellar ataxia with axonal neuropathy (SCAN1). We investigated the catalytic role of this histidine in the yeast protein (His432) using a combination of X-ray crystallography, biochemistry, yeast genetics, and theoretical chemistry. The structures of wild-type Tdp1 and His432Arg both show a phosphorylated form of the nucleophilic histidine that is not observed in the structure of His432Asn. The phosphohistidine is stabilized in the His432Arg structure by the guanidinium group that also restricts the access of nucleophilic water molecule to the Tdp1-DNA intermediate. Biochemical analyses confirm that His432Arg forms an observable and unique Tdp1-DNA adduct during catalysis. Substitution of His432 by Lys does not affect catalytic activity or yeast phenotype, but substitutions with Asn, Gln, Leu, Ala, Ser, and Thr all result in severely compromised enzymes and DNA topoisomerase I-camptothecin dependent lethality. Surprisingly, His432Asn did not show a stable covalent Tdp1-DNA intermediate that suggests another catalytic defect. Theoretical calculations revealed that the defect resides in the nucleophilic histidine and that the pK(a) of this histidine is crucially dependent on the second histidine and on the incoming phosphate of the substrate. This represents a unique example of substrate-activated catalysis that applies to the entire phospholipase D superfamily.

Indexed as

Catalytic DomainCrystallography, X-RayHistidineHumansKineticsModels, BiologicalModels, MolecularMolecular Dynamics SimulationMultigene FamilyMutagenesis, Site-DirectedMutant ProteinsOrganisms, Genetically ModifiedPhospholipase DPhosphoric Diester HydrolasesYeastsHistidineMutant ProteinsPhospholipase DPhosphoric Diester Hydrolasestyrosyl-DNA phosphodiesterase

Identifiers

PMID22155078
PMCPMC3265611
OpenAlexW1972963751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.